News | January 31, 2014

Gore, AAAneurysm Outreach to Increase Early Detection of Abdominal Aortic Aneurysm

Campaign focuses on awareness, community outreach, patient screening

Gore AAAneurysm Outreach Abdominal Aortic Aneurysm AAA Stent Graphs
January 31, 2014 — W. L. Gore & Associates Inc. (Gore) and AAAneurysm Outreach have partnered to raise awareness and drive screening of individuals at-risk of abdominal aortic aneurysm (AAA). The organizations aim to increase programming and education for clinicians and those at risk of AAA, a potentially life-threatening condition caused by a balloon-like of the abdominal aorta.
 
The partnership and resulting campaign will focus on three key initiatives: awareness, outreach and screening. Raising awareness of AAA through community engagement is a cornerstone of both AAAneurysm Outreach’s approach and Gore’s commitment to patient and clinical groups. AAAneurysm Outreach and Gore will launch an AAA Community Speaker Series where survivors, advocates, providers and at-risk individuals will share experiences and examine issues related to AAA.
 
Through outreach efforts, Gore and AAAneurysm Outreach will provide materials intended to enhance primary care physicians’ understanding of AAA diagnosis and treatment. The campaign will provide primary care physicians with toolkits to support interaction and communication with vascular surgeons, interventional cardiologists and radiologists within their region.
 
Finally, the campaign will organize and conduct AAA screenings for those at risk. A key element of this effort will include the AAA Screening Tour, which will empower the patient community to understand risks and facts about AAA. Collaborating with regional healthcare providers, the organizations aim to screen up to 300 individuals at each event.
 
At-risk individuals include those over the age of 60, those with a history of smoking and those with a family history of AAA. 
 
For more information: www.aoutreach.org, www.gore.com

Related Content

FDA Grants Breakthrough Device Designation for Valiant Thoracoabdominal Aortic Aneurysm Stent Graft
News | Stent Grafts | October 09, 2019
Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA...
PQ Bypass Granted IDE Approval to Start TORUS SFA Stent Graft Pivotal Study
News | Stent Grafts | October 08, 2019
PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) trial of the...
First U.S. Patient Receives Gore Tag Conformable Thoracic Stent Graft With Active Control
News | Stent Grafts | July 10, 2019
W. L. Gore & Associates Inc. (Gore) announced the first U.S. implant of the Gore Tag Conformable Thoracic Stent...
Gore Receives FDA Approval for Gore Tag Conformable Thoracic Stent Graft
Technology | Stent Grafts | May 15, 2019
W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted regulatory...
Aortic Stent Graft Global Market to Reach $5.4 Billion by 2028
News | Stent Grafts | February 14, 2019
Abdominal aortic stent grafts will remain the largest segment in the global aortic stent graft market at least through...
Medtronic Receives FDA Approval for Valiant Navion Thoracic Stent Graft System
Technology | Stent Grafts | February 07, 2019
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for the Valiant Navion thoracic stent...
Endologix Ends Unrestricted Sales and Use of Nellix System
News | Stent Grafts | January 07, 2019
January 7, 2019 — Endologix Inc.
Endologix Reports Positive One-Year Results From the Ovation LUCY Study
News | Stent Grafts | July 16, 2018
Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for...
FDA Committee Votes in Favor of Incraft AAA Stent Graft System
News | Stent Grafts | June 13, 2018
Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has received a favorable...
First Patient Enrolled in Gore Excluder Investigational Study
News | Stent Grafts | January 08, 2018
January 8, 2018 — W. L. Gore & Associates Inc.
Overlay Init